Skip to main content

Table 4 Demographic and clinical presentations of MRSA and V. vulnificus associated necrotizing fasciitis patients

From: Bacteriology and mortality of necrotizing fasciitis in a tertiary coastal hospital with comparing risk indicators of methicillin-resistant Staphylococcus aureus and Vibrio vulnificus infections: a prospective study

Characteristics

MRSA

(N-16)

Vibrio vulnificus

(N-40)

p-value

Age (years)

   

 Mean

62.8

71.2

0.35

Gender

   

 Female

5

14

0.52

 Male

11

26

Comorbidities (%)

   

 Hepatic dysfunction

5 (31.2)

25 (62.5)

0.034*

 LC alone or with others

3 (18.75)

7 (17.5)

1

 Diabetic mellitus

8 (50)

12 (20)

0.136

 Cancer

2 (12.5)

2 (5)

0.321

 Chronic kidney disease

4 (25)

10 (25)

0.624

Interval from contact or injury

5.5

1.2

0.023*

to presentation at ER (days)

   

Interval from diagnosis at ER

5.8

4.7

0.53

to first operation (hours)

   

Wound location (%)

   

 Upper extremity

8 (50)

24 (60)

0.489

 Lower extremity

8 (50)

16 (40)

Outcome

6.25%

10%

 

 Death

1

4

0.383

 Survivors

15

36

Related events (%)

   

 Seawater or seafood contact

2 (12.5)

37 (92.5)

0.001*

 Farm/dirty-water contacted

1 (6.25)

3 (7.5)

0.43

Vital signs (%)

   

 Body temperature > 38 °C

4 (25)

8 (20)

0.376

 Heart rate ≥ 100

10 (62.5)

22 (55)

0.607

 Respiratory rate > 20

7 (43.75)

23 (57.5)

0.325

 Systolic blood pressure < 90

0

9 (22.5)

0.036*

Cultures (%)

   

 Blood (P) Wound (P)

3 (18.75)

15 (37.5)

 

 Blood (P) Wound (N)

0

11 (27.5)

 

 Blood (N) Wound (P)

13 (81.25)

14 (35)

 

Presence of bacteremia (%)

3 (18.75)

26 (65)

0.002*

  1. Blood (P), culture-positive blood sample; Blood (N), culture-negative blood sample; Wound (P), culture-positive surgical wound sample; Wound (N), culture-negative surgical wound sample
  2. Hepatic dysfunction included liver cirrhosis (LC), hepatitis B or C, hepatocellular carcinoma, and alcoholic liver disease
  3. *Mean p < 0.05 and the difference was significant